| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Strata Critical Medical, Inc. (SRTA) has 14 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. SRTA is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $28.94M | - | |
| CEO | 1.64M | $9.01M | - | |
| CEO | 1.37M | $7.50M | - | |
| CEO | 1.13M | $6.22M | - | |
| CEO | 293.4K | $1.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | Heyburn William A.57 | Co-ceo And CFO | Buy | 17,000 | $4.47 | $76,044.40 | +1.2% | +0.7% | - | |
| Dec 5, 2025 | Lauck Andrew | Director | Buy | 5,000 | $4.37 | $21,825.00 | +3.8% | +9.2% | - | |
| Nov 20, 2025 | Love Reginald53 | Director | Sell | 11,000 | $4.37 | $48,070.00 | -8.8% | +14.6% | - | |
| Nov 19, 2025 | Love Reginald53 | Director | Sell | 11,000 | $4.31 | $47,434.20 | -8.1% | +5.9% | - | |
| Aug 4, 2025 | Tomkiel Melissa M.57 | President And General Counsel | Sell | 47,995 | $4.94 | $237,133.70 | -4.0% | +15.1% | - | |
| Aug 4, 2025 | Heyburn William A.57 | Chief Financial Officer | Sell | 46,918 | $4.94 | $231,821.84 | -3.4% | +15.1% | - | |
| Jun 9, 2025 | Tomkiel Melissa M.57 | President And General Counsel | Sell | 100,000 | $4.08 | $407,530.00 | -8.0% | -5.7% | - | |
| Jun 9, 2025 | Heyburn William A.57 | Chief Financial Officer | Sell | 100,000 | $4.07 | $406,590.00 | -6.8% | -5.7% | - | |
| Jan 7, 2025 | Heyburn William A.57 | Chief Financial Officer | Sale+OE | 104,570 | $5.02 | $525,019.67 | -4.1% | -44.3% | +25.1% | |
| Dec 13, 2024 | Borthwick John | Director | Sale+OE | 78,291 | $4.00 | $313,250.12 | -31.7% | -25.0% | +26.7% |